Axel Bolte
Investment Advisor, HBM Partners

Keith Bostian, Ph.D.
Former Chief Scientific Officer

Daniel D. Burgess
President and Chief Executive Officer

Kenneth Kelley
Managing Director, K2 Bioventures

Daniel Kisner, M.D.
Partner, Aberdare Ventures

Scott R. Pancoast
President and CEO, Lpath Therapeutics

Michael J. Ross, Ph.D.
General Partner, SV Life Sciences